Abeona Therapeutics ABEO
NASDAQ ABEO
$5.03 +0.02 (+0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Gains from Sales and Divestitures (2022 - 2023)

Updated

Abeona Therapeutics' Gains from Sales and Divestitures came in at $2,000 for FY2024, compared with -$47,000 in FY2023.

Analysis

Abeona Therapeutics (ABEO) Gains from Sales and Divestitures (2022 - 2023) Analysis & Trends

Going back to FY2017, Abeona Therapeutics' Gains from Sales and Divestitures data covers 4 years.

  • The FY2024 figure represents the highest annual Gains from Sales and Divestitures since FY2017.
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$47,000 in FY2023 and -$138,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Abeona Therapeutics 287.85 Mn -426.11 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 5,000.00
Sep 30, 2023 -5,000.00
Dec 31, 2022 -17,000.00
Sep 30, 2022 -15,000.00
API Access

Abeona Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ABEO&period=max&api_key=YOUR_API_KEY